Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) saw strong trading volume on Monday . 15,000 shares were traded during mid-day trading, an increase of 107% from the previous session’s volume of 7,235 shares.The stock last traded at $7.99 and had previously closed at $8.00.
Oxford BioMedica Stock Performance
The business has a 50 day moving average of $8.21 and a 200 day moving average of $8.96.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Featured Articles
- Five stocks we like better than Oxford BioMedica
- Doug Casey Calls AI a Super Bubble, Bets on Energy, Gold Miners and Grains
- This Edge AI Stock Just Got a Huge Vote of Confidence From Wall Street
- AI Is Selling Off, But These 5 Stocks Could Benefit Next
- These 3 Stocks Offer Investors Exposure to the Functional Beverage Boom
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
